Page last updated: 2024-09-03

san 58035 and cyclandelate

san 58035 has been researched along with cyclandelate in 1 studies

Compound Research Comparison

Studies (san 58035)	Trials (san 58035)	Recent Studies (post-2010) (san 58035)	Studies (cyclandelate)	Trials (cyclandelate)	Recent Studies (post-2010) (cyclandelate)
58	1	12	146	33	5

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Middleton, B	1

Other Studies

1 other study(ies) available for san 58035 and cyclandelate

Article	Year
Inhibition of cellular cholesterol esterification can decrease low density lipoprotein receptor number in human fibroblasts. Biochemical and biophysical research communications, 1987, May-29, Volume: 145, Issue:1 Topics: Amides; Cells, Cultured; Cholesterol Esters; Cyclandelate; Fibroblasts; Humans; Lipoproteins, LDL; Organosilicon Compounds; Progesterone; Receptors, LDL; Skin; Sterol O-Acyltransferase	1987

Article

Year

Inhibition of cellular cholesterol esterification can decrease low density lipoprotein receptor number in human fibroblasts.

Biochemical and biophysical research communications, 1987, May-29, Volume: 145, Issue:1

Topics: Amides; Cells, Cultured; Cholesterol Esters; Cyclandelate; Fibroblasts; Humans; Lipoproteins, LDL; Organosilicon Compounds; Progesterone; Receptors, LDL; Skin; Sterol O-Acyltransferase

1987